CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis
2008 · British Journal of Cancer · 434 citations
https://doi.org/10.1038/sj.bjc.6604242
W
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
268
Papers
18.5K
Citations
76
h-index
188
i10-index
William L. Farrar is an academic researcher from The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. The author has contributed to research in topics: Cytokine Signaling Pathways and Interactions & Immune Cell Function and Interaction & T-cell and B-cell Immunology. The author has an h-index of 76, co-authored 228 publications.
Papers by this author
worksJAK3, STAT, and MAPK Signaling Pathways as Novel Molecular Targets for the Tyrphostin AG-490 Regulation of IL-2-Mediated T Cell Response
1999 · The Journal of Immunology · 162 citations
https://doi.org/10.4049/jimmunol.162.7.3897
Specific inhibition of c- <i>myc</i> protein biosynthesis using an antisense synthetic deoxy-oligonucleotide in human T lymphocytes.
1988 · The Journal of Immunology · 118 citations
https://doi.org/10.4049/jimmunol.140.7.2431
Molecular consequences of SOD2 expression in epigenetically silenced pancreatic carcinoma cell lines
2007 · British Journal of Cancer · 76 citations
https://doi.org/10.1038/sj.bjc.6604000
Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells
2010 · Molecular Cancer · 41 citations
https://doi.org/10.1186/1476-4598-9-267
DNA repair: the culprit for tumor-initiating cell survival?
2011 · Cancer and Metastasis Reviews · 37 citations
https://doi.org/10.1007/s10555-011-9277-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat